The Fitness Cost of Antibiotic Resistance in Streptococcus pneumoniae: Insight from the Field
Open Access
- 17 January 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (1), e29407
- https://doi.org/10.1371/journal.pone.0029407
Abstract
Laboratory studies have suggested that antibiotic resistance may result in decreased fitness in the bacteria that harbor it. Observational studies have supported this, but due to ethical and practical considerations, it is rare to have experimental control over antibiotic prescription rates. We analyze data from a 54-month longitudinal trial that monitored pneumococcal drug resistance during and after biannual mass distribution of azithromycin for the elimination of the blinding eye disease, trachoma. Prescription of azithromycin and antibiotics that can create cross-resistance to it is rare in this part of the world. As a result, we were able to follow trends in resistance with minimal influence from unmeasured antibiotic use. Using these data, we fit a probabilistic disease transmission model that included two resistant strains, corresponding to the two dominant modes of resistance to macrolide antibiotics. We estimated the relative fitness of these two strains to be 0.86 (95% CI 0.80 to 0.90), and 0.88 (95% CI 0.82 to 0.93), relative to antibiotic-sensitive strains. We then used these estimates to predict that, within 5 years of the last antibiotic treatment, there would be a 95% chance of elimination of macrolide resistance by intra-species competition alone. Although it is quite possible that the fitness cost of macrolide resistance is sufficient to ensure its eventual elimination in the absence of antibiotic selection, this process takes time, and prevention is likely the best policy in the fight against resistance.Keywords
This publication has 29 references indexed in Scilit:
- Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical TrialPLoS Medicine, 2010
- Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal diseaseBMC Infectious Diseases, 2010
- What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae ?Journal of The Royal Society Interface, 2009
- The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosisProceedings of the National Academy of Sciences of the United States of America, 2009
- Interplay in the Selection of Fluoroquinolone Resistance and Bacterial FitnessPLoS Pathogens, 2009
- Seasonality of Antibiotic‐ResistantStreptococcus pneumoniaeThat Causes Acute Otitis Media: A Clue for an Antibiotic‐Restriction Policy?The Journal of Infectious Diseases, 2008
- Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in JapanJournal of Clinical Microbiology, 2007
- Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2007
- In Vivo Survival of Teicoplanin-Resistant Staphylococcus aureus and Fitness Cost of Teicoplanin ResistanceAntimicrobial Agents and Chemotherapy, 2006